nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—melanoma	0.477	1	CbGaD
Aminosalicylic Acid—Cutaneous hypersensitivity—Docetaxel—melanoma	0.00468	0.0466	CcSEcCtD
Aminosalicylic Acid—MPO—endothelium—melanoma	0.00433	0.0884	CbGeAlD
Aminosalicylic Acid—PTGS2—leg—melanoma	0.00425	0.0867	CbGeAlD
Aminosalicylic Acid—MPO—blood vessel—melanoma	0.004	0.0815	CbGeAlD
Aminosalicylic Acid—CHUK—skin of body—melanoma	0.00388	0.0792	CbGeAlD
Aminosalicylic Acid—PTGS2—hindlimb—melanoma	0.0038	0.0774	CbGeAlD
Aminosalicylic Acid—Vasculitis—Vemurafenib—melanoma	0.00344	0.0343	CcSEcCtD
Aminosalicylic Acid—PTGS2—appendage—melanoma	0.00326	0.0664	CbGeAlD
Aminosalicylic Acid—Eruption—Dactinomycin—melanoma	0.00309	0.0308	CcSEcCtD
Aminosalicylic Acid—Encephalopathy—Carmustine—melanoma	0.00277	0.0276	CcSEcCtD
Aminosalicylic Acid—PTGS2—skin epidermis—melanoma	0.00271	0.0553	CbGeAlD
Aminosalicylic Acid—CHUK—head—melanoma	0.00253	0.0517	CbGeAlD
Aminosalicylic Acid—PTGS1—endothelium—melanoma	0.00206	0.042	CbGeAlD
Aminosalicylic Acid—PTGS2—endothelium—melanoma	0.00197	0.0401	CbGeAlD
Aminosalicylic Acid—Weight decreased—Vemurafenib—melanoma	0.00191	0.019	CcSEcCtD
Aminosalicylic Acid—PTGS1—blood vessel—melanoma	0.0019	0.0387	CbGeAlD
Aminosalicylic Acid—Eruption—Docetaxel—melanoma	0.00186	0.0185	CcSEcCtD
Aminosalicylic Acid—MPO—skin of body—melanoma	0.00185	0.0378	CbGeAlD
Aminosalicylic Acid—Neuropathy peripheral—Vemurafenib—melanoma	0.00184	0.0184	CcSEcCtD
Aminosalicylic Acid—PTGS2—blood vessel—melanoma	0.00181	0.037	CbGeAlD
Aminosalicylic Acid—CHUK—lymph node—melanoma	0.00177	0.0362	CbGeAlD
Aminosalicylic Acid—Dermatitis atopic—Docetaxel—melanoma	0.00154	0.0154	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Vemurafenib—melanoma	0.00147	0.0146	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Vemurafenib—melanoma	0.00144	0.0143	CcSEcCtD
Aminosalicylic Acid—ALOX5—head—melanoma	0.00143	0.0291	CbGeAlD
Aminosalicylic Acid—Vascular purpura—Temozolomide—melanoma	0.00139	0.0139	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PPARG—melanoma	0.00138	0.307	CrCbGaD
Aminosalicylic Acid—Dermatitis exfoliative—Temozolomide—melanoma	0.00132	0.0132	CcSEcCtD
Aminosalicylic Acid—Purpura—Temozolomide—melanoma	0.00129	0.0129	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00129	0.0129	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00124	0.0124	CcSEcCtD
Aminosalicylic Acid—MPO—head—melanoma	0.00121	0.0246	CbGeAlD
Aminosalicylic Acid—Nervous system disorder—Vemurafenib—melanoma	0.00118	0.0117	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Vemurafenib—melanoma	0.00116	0.0116	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Bleomycin—melanoma	0.00116	0.0115	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Temozolomide—melanoma	0.00108	0.0108	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Vemurafenib—melanoma	0.00104	0.0104	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Vemurafenib—melanoma	0.00103	0.0103	CcSEcCtD
Aminosalicylic Acid—ALOX5—lymph node—melanoma	0.000999	0.0204	CbGeAlD
Aminosalicylic Acid—Agranulocytosis—Dactinomycin—melanoma	0.000991	0.00988	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Temozolomide—melanoma	0.000975	0.00971	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Carmustine—melanoma	0.000974	0.00971	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Dactinomycin—melanoma	0.000953	0.0095	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Vemurafenib—melanoma	0.000948	0.00944	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Temozolomide—melanoma	0.000942	0.00938	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Vemurafenib—melanoma	0.000883	0.0088	CcSEcCtD
Aminosalicylic Acid—PTGS1—skin of body—melanoma	0.000878	0.0179	CbGeAlD
Aminosalicylic Acid—Hepatitis—Temozolomide—melanoma	0.000862	0.00859	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Temozolomide—melanoma	0.000852	0.00849	CcSEcCtD
Aminosalicylic Acid—MPO—lymph node—melanoma	0.000845	0.0172	CbGeAlD
Aminosalicylic Acid—Urethral disorder—Temozolomide—melanoma	0.000845	0.00842	CcSEcCtD
Aminosalicylic Acid—PTGS2—skin of body—melanoma	0.000839	0.0171	CbGeAlD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000829	0.00826	CcSEcCtD
Aminosalicylic Acid—Anaemia—Bleomycin—melanoma	0.000822	0.0082	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Vemurafenib—melanoma	0.00082	0.00817	CcSEcCtD
Aminosalicylic Acid—PTGS1—mammalian vulva—melanoma	0.000801	0.0163	CbGeAlD
Aminosalicylic Acid—Leukopenia—Bleomycin—melanoma	0.000797	0.00794	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vemurafenib—melanoma	0.000793	0.0079	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Carmustine—melanoma	0.000777	0.00774	CcSEcCtD
Aminosalicylic Acid—Anaemia—Dactinomycin—melanoma	0.000767	0.00765	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vemurafenib—melanoma	0.000762	0.0076	CcSEcCtD
Aminosalicylic Acid—Rash—Vemurafenib—melanoma	0.000756	0.00753	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Vemurafenib—melanoma	0.000755	0.00753	CcSEcCtD
Aminosalicylic Acid—Headache—Vemurafenib—melanoma	0.000751	0.00748	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Temozolomide—melanoma	0.000751	0.00748	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Dactinomycin—melanoma	0.000743	0.0074	CcSEcCtD
Aminosalicylic Acid—Diflunisal—PTGS2—melanoma	0.000742	0.165	CrCbGaD
Aminosalicylic Acid—Dysgeusia—Temozolomide—melanoma	0.000735	0.00733	CcSEcCtD
Aminosalicylic Acid—Anaemia—Carmustine—melanoma	0.000718	0.00716	CcSEcCtD
Aminosalicylic Acid—Nausea—Vemurafenib—melanoma	0.000712	0.0071	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Bleomycin—melanoma	0.000711	0.00709	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Carmustine—melanoma	0.000695	0.00693	CcSEcCtD
Aminosalicylic Acid—Anaemia—Temozolomide—melanoma	0.000694	0.00692	CcSEcCtD
Aminosalicylic Acid—Anorexia—Bleomycin—melanoma	0.000692	0.0069	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Temozolomide—melanoma	0.000672	0.0067	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dactinomycin—melanoma	0.000663	0.00661	CcSEcCtD
Aminosalicylic Acid—Diflunisal—ALB—melanoma	0.000661	0.147	CrCbGaD
Aminosalicylic Acid—Weight decreased—Docetaxel—melanoma	0.000648	0.00646	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dactinomycin—melanoma	0.000646	0.00644	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000635	0.00633	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Bleomycin—melanoma	0.000631	0.00629	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Docetaxel—melanoma	0.000626	0.00624	CcSEcCtD
Aminosalicylic Acid—Jaundice—Docetaxel—melanoma	0.000623	0.00621	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Carmustine—melanoma	0.000621	0.00619	CcSEcCtD
Aminosalicylic Acid—Anorexia—Carmustine—melanoma	0.000604	0.00602	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Temozolomide—melanoma	0.000601	0.00599	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Temozolomide—melanoma	0.0006	0.00598	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Docetaxel—melanoma	0.000596	0.00594	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Temozolomide—melanoma	0.000595	0.00593	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dactinomycin—melanoma	0.000589	0.00587	CcSEcCtD
Aminosalicylic Acid—Anorexia—Temozolomide—melanoma	0.000584	0.00582	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS2—melanoma	0.000582	0.13	CrCbGaD
Aminosalicylic Acid—Urticaria—Bleomycin—melanoma	0.000577	0.00575	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Bleomycin—melanoma	0.000574	0.00572	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Docetaxel—melanoma	0.000573	0.00572	CcSEcCtD
Aminosalicylic Acid—PTGS1—head—melanoma	0.000573	0.0117	CbGeAlD
Aminosalicylic Acid—Urinary tract disorder—Docetaxel—melanoma	0.000566	0.00564	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Docetaxel—melanoma	0.000562	0.0056	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dactinomycin—melanoma	0.000554	0.00552	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Carmustine—melanoma	0.000551	0.00549	CcSEcCtD
Aminosalicylic Acid—PTGS2—head—melanoma	0.000547	0.0112	CbGeAlD
Aminosalicylic Acid—Gastrointestinal disorder—Carmustine—melanoma	0.000547	0.00545	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dactinomycin—melanoma	0.000535	0.00534	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dactinomycin—melanoma	0.000535	0.00534	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Bleomycin—melanoma	0.000535	0.00533	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Temozolomide—melanoma	0.000533	0.00531	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Temozolomide—melanoma	0.000529	0.00527	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Carmustine—melanoma	0.000518	0.00517	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Carmustine—melanoma	0.000501	0.00499	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Carmustine—melanoma	0.000501	0.00499	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Temozolomide—melanoma	0.000501	0.00499	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Docetaxel—melanoma	0.000499	0.00498	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Dactinomycin—melanoma	0.000499	0.00497	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Docetaxel—melanoma	0.000489	0.00487	CcSEcCtD
Aminosalicylic Acid—Urticaria—Temozolomide—melanoma	0.000487	0.00485	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Temozolomide—melanoma	0.000484	0.00483	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Temozolomide—melanoma	0.000484	0.00483	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Carmustine—melanoma	0.000467	0.00466	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dactinomycin—melanoma	0.000463	0.00462	CcSEcCtD
Aminosalicylic Acid—Vomiting—Bleomycin—melanoma	0.000462	0.0046	CcSEcCtD
Aminosalicylic Acid—Anaemia—Docetaxel—melanoma	0.000461	0.0046	CcSEcCtD
Aminosalicylic Acid—Rash—Bleomycin—melanoma	0.000458	0.00456	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Bleomycin—melanoma	0.000457	0.00456	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Temozolomide—melanoma	0.000451	0.0045	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Docetaxel—melanoma	0.000447	0.00445	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Carmustine—melanoma	0.000434	0.00432	CcSEcCtD
Aminosalicylic Acid—Nausea—Bleomycin—melanoma	0.000431	0.0043	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dactinomycin—melanoma	0.000431	0.00429	CcSEcCtD
Aminosalicylic Acid—Rash—Dactinomycin—melanoma	0.000427	0.00426	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000422	0.00421	CcSEcCtD
Aminosalicylic Acid—Dizziness—Carmustine—melanoma	0.000419	0.00418	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Temozolomide—melanoma	0.000419	0.00418	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—melanoma	0.000413	0.0918	CrCbGaD
Aminosalicylic Acid—Dizziness—Temozolomide—melanoma	0.000405	0.00404	CcSEcCtD
Aminosalicylic Acid—Vomiting—Carmustine—melanoma	0.000403	0.00402	CcSEcCtD
Aminosalicylic Acid—Nausea—Dactinomycin—melanoma	0.000402	0.00401	CcSEcCtD
Aminosalicylic Acid—PTGS1—lymph node—melanoma	0.000401	0.00818	CbGeAlD
Aminosalicylic Acid—Rash—Carmustine—melanoma	0.0004	0.00398	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Docetaxel—melanoma	0.0004	0.00398	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Carmustine—melanoma	0.000399	0.00398	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Docetaxel—melanoma	0.000399	0.00398	CcSEcCtD
Aminosalicylic Acid—Headache—Carmustine—melanoma	0.000397	0.00396	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Docetaxel—melanoma	0.000396	0.00394	CcSEcCtD
Aminosalicylic Acid—Vomiting—Temozolomide—melanoma	0.00039	0.00388	CcSEcCtD
Aminosalicylic Acid—Anorexia—Docetaxel—melanoma	0.000388	0.00387	CcSEcCtD
Aminosalicylic Acid—Rash—Temozolomide—melanoma	0.000386	0.00385	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Temozolomide—melanoma	0.000386	0.00385	CcSEcCtD
Aminosalicylic Acid—Headache—Temozolomide—melanoma	0.000384	0.00383	CcSEcCtD
Aminosalicylic Acid—PTGS2—lymph node—melanoma	0.000383	0.00782	CbGeAlD
Aminosalicylic Acid—Nausea—Carmustine—melanoma	0.000377	0.00375	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ALB—melanoma	0.000368	0.0818	CrCbGaD
Aminosalicylic Acid—Nausea—Temozolomide—melanoma	0.000364	0.00363	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Docetaxel—melanoma	0.000354	0.00353	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Docetaxel—melanoma	0.000352	0.00351	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ABCB1—melanoma	0.000351	0.0781	CrCbGaD
Aminosalicylic Acid—Gastrointestinal pain—Docetaxel—melanoma	0.000333	0.00332	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Docetaxel—melanoma	0.000322	0.00321	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Docetaxel—melanoma	0.000322	0.00321	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Docetaxel—melanoma	0.0003	0.00299	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Docetaxel—melanoma	0.000279	0.00278	CcSEcCtD
Aminosalicylic Acid—Dizziness—Docetaxel—melanoma	0.000269	0.00269	CcSEcCtD
Aminosalicylic Acid—Vomiting—Docetaxel—melanoma	0.000259	0.00258	CcSEcCtD
Aminosalicylic Acid—Rash—Docetaxel—melanoma	0.000257	0.00256	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Docetaxel—melanoma	0.000257	0.00256	CcSEcCtD
Aminosalicylic Acid—Headache—Docetaxel—melanoma	0.000255	0.00254	CcSEcCtD
Aminosalicylic Acid—Nausea—Docetaxel—melanoma	0.000242	0.00241	CcSEcCtD
Aminosalicylic Acid—CHUK—Innate Immune System—NFKB1—melanoma	2.57e-05	6.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.56e-05	6.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.53e-05	6.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HLA-A—melanoma	2.49e-05	6.75e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TERT—melanoma	2.49e-05	6.75e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDKN1A—melanoma	2.49e-05	6.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RAC1—melanoma	2.49e-05	6.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTEN—melanoma	2.48e-05	6.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GNA11—melanoma	2.48e-05	6.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—VCAN—melanoma	2.47e-05	6.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NFKB1—melanoma	2.47e-05	6.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR4—melanoma	2.47e-05	6.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DRB1—melanoma	2.47e-05	6.68e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SYK—melanoma	2.43e-05	6.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—FASN—melanoma	2.43e-05	6.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC5A5—melanoma	2.39e-05	6.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ITGAV—melanoma	2.38e-05	6.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NGFR—melanoma	2.38e-05	6.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT3—melanoma	2.38e-05	6.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HIF1A—melanoma	2.38e-05	6.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ICAM1—melanoma	2.37e-05	6.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GAB2—melanoma	2.35e-05	6.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.34e-05	6.34e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CB—melanoma	2.32e-05	6.28e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NRAS—melanoma	2.31e-05	6.25e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GNAQ—melanoma	2.31e-05	6.25e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CD44—melanoma	2.31e-05	6.25e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FASN—melanoma	2.3e-05	6.24e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—melanoma	2.3e-05	6.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD80—melanoma	2.28e-05	6.18e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KIT—melanoma	2.27e-05	6.16e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.26e-05	6.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.26e-05	6.12e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGF—melanoma	2.25e-05	6.09e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.24e-05	6.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NRAS—melanoma	2.22e-05	6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP1B1—melanoma	2.21e-05	5.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CXCR4—melanoma	2.21e-05	5.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FOXO4—melanoma	2.21e-05	5.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HDAC2—melanoma	2.21e-05	5.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK3—melanoma	2.21e-05	5.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SOCS1—melanoma	2.21e-05	5.98e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—S100B—melanoma	2.2e-05	5.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD44—melanoma	2.19e-05	5.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS2—melanoma	2.17e-05	5.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOTCH1—melanoma	2.15e-05	5.82e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.14e-05	5.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CASP8—melanoma	2.12e-05	5.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB4—melanoma	2.11e-05	5.71e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD80—melanoma	2.1e-05	5.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK1—melanoma	2.1e-05	5.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—melanoma	2.1e-05	5.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APC—melanoma	2.1e-05	5.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KIT—melanoma	2.1e-05	5.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDH1—melanoma	2.09e-05	5.67e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN2B—melanoma	2.09e-05	5.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP17A1—melanoma	2.09e-05	5.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGF—melanoma	2.08e-05	5.63e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.06e-05	5.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.03e-05	5.5e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD86—melanoma	2.02e-05	5.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—melanoma	2.02e-05	5.47e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT3—melanoma	2.02e-05	5.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAP2K1—melanoma	2.01e-05	5.45e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTEN—melanoma	2e-05	5.43e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EDN1—melanoma	2e-05	5.43e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CD—melanoma	2e-05	5.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KRAS—melanoma	1.99e-05	5.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—BRAF—melanoma	1.97e-05	5.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GNA11—melanoma	1.97e-05	5.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CSF2—melanoma	1.96e-05	5.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF1—melanoma	1.96e-05	5.31e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.95e-05	5.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—FASN—melanoma	1.93e-05	5.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—E2F1—melanoma	1.92e-05	5.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGF2—melanoma	1.91e-05	5.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KRAS—melanoma	1.91e-05	5.17e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDGFRA—melanoma	1.9e-05	5.14e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC5A5—melanoma	1.9e-05	5.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ITGB3—melanoma	1.88e-05	5.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRKCA—melanoma	1.88e-05	5.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAP2K1—melanoma	1.86e-05	5.04e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CD—melanoma	1.85e-05	5e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SPP1—melanoma	1.84e-05	4.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAP2K2—melanoma	1.84e-05	4.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GNAQ—melanoma	1.83e-05	4.96e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CD44—melanoma	1.83e-05	4.96e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CA—melanoma	1.82e-05	4.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCB1—melanoma	1.82e-05	4.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2—melanoma	1.82e-05	4.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—melanoma	1.8e-05	4.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.79e-05	4.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MDM2—melanoma	1.79e-05	4.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB4—melanoma	1.78e-05	4.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGF2—melanoma	1.77e-05	4.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN2B—melanoma	1.77e-05	4.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB2—melanoma	1.77e-05	4.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP1B1—melanoma	1.76e-05	4.76e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CA—melanoma	1.75e-05	4.75e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TERT—melanoma	1.75e-05	4.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CB—melanoma	1.74e-05	4.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RAC1—melanoma	1.74e-05	4.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—melanoma	1.74e-05	4.71e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD86—melanoma	1.71e-05	4.63e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—melanoma	1.69e-05	4.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PRKCA—melanoma	1.68e-05	4.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HIF1A—melanoma	1.67e-05	4.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ERCC2—melanoma	1.66e-05	4.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF1—melanoma	1.66e-05	4.49e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MDM2—melanoma	1.65e-05	4.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1B—melanoma	1.64e-05	4.43e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB2—melanoma	1.63e-05	4.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—melanoma	1.62e-05	4.39e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—melanoma	1.62e-05	4.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CB—melanoma	1.61e-05	4.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—melanoma	1.61e-05	4.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFRA—melanoma	1.6e-05	4.35e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—melanoma	1.6e-05	4.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KDR—melanoma	1.6e-05	4.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—melanoma	1.59e-05	4.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PRKCA—melanoma	1.59e-05	4.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERCC2—melanoma	1.58e-05	4.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAP2K2—melanoma	1.55e-05	4.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.55e-05	4.2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTNNB1—melanoma	1.55e-05	4.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FN1—melanoma	1.54e-05	4.16e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1B—melanoma	1.51e-05	4.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1A—melanoma	1.51e-05	4.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTEN—melanoma	1.51e-05	4.08e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH1—melanoma	1.5e-05	4.08e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NFKB1—melanoma	1.5e-05	4.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—melanoma	1.49e-05	4.04e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HLA-A—melanoma	1.48e-05	4e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TERT—melanoma	1.48e-05	4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD80—melanoma	1.47e-05	3.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RAC1—melanoma	1.47e-05	3.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CG—melanoma	1.47e-05	3.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APC—melanoma	1.47e-05	3.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KIT—melanoma	1.47e-05	3.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGF—melanoma	1.45e-05	3.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCB1—melanoma	1.45e-05	3.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—melanoma	1.43e-05	3.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CTNNB1—melanoma	1.43e-05	3.87e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CA—melanoma	1.41e-05	3.83e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HIF1A—melanoma	1.41e-05	3.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1A—melanoma	1.39e-05	3.78e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTEN—melanoma	1.39e-05	3.77e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BRAF—melanoma	1.38e-05	3.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.38e-05	3.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—melanoma	1.35e-05	3.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1—melanoma	1.35e-05	3.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NRAS—melanoma	1.34e-05	3.64e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PRKCA—melanoma	1.33e-05	3.6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ERCC2—melanoma	1.32e-05	3.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CG—melanoma	1.31e-05	3.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAP2K1—melanoma	1.3e-05	3.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CD—melanoma	1.29e-05	3.5e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK3—melanoma	1.29e-05	3.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—melanoma	1.28e-05	3.48e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOTCH1—melanoma	1.27e-05	3.45e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—melanoma	1.27e-05	3.43e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD80—melanoma	1.25e-05	3.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KIT—melanoma	1.24e-05	3.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APC—melanoma	1.24e-05	3.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—melanoma	1.24e-05	3.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NRAS—melanoma	1.24e-05	3.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF2—melanoma	1.24e-05	3.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGF—melanoma	1.23e-05	3.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK1—melanoma	1.22e-05	3.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—melanoma	1.22e-05	3.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAPK3—melanoma	1.19e-05	3.22e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BRAF—melanoma	1.17e-05	3.17e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MDM2—melanoma	1.16e-05	3.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KRAS—melanoma	1.16e-05	3.13e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—melanoma	1.16e-05	3.13e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—melanoma	1.15e-05	3.13e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CD—melanoma	1.15e-05	3.13e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB2—melanoma	1.14e-05	3.09e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—melanoma	1.14e-05	3.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAPK1—melanoma	1.13e-05	3.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—melanoma	1.13e-05	3.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CB—melanoma	1.13e-05	3.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAP2K1—melanoma	1.1e-05	2.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CD—melanoma	1.09e-05	2.96e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.09e-05	2.96e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL8—melanoma	1.08e-05	2.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KRAS—melanoma	1.07e-05	2.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CA—melanoma	1.06e-05	2.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1B—melanoma	1.06e-05	2.87e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF2—melanoma	1.05e-05	2.84e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CG—melanoma	1.04e-05	2.82e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—melanoma	1.04e-05	2.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—melanoma	1.03e-05	2.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCND1—melanoma	1.01e-05	2.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CB—melanoma	1.01e-05	2.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—melanoma	1.01e-05	2.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CTNNB1—melanoma	9.99e-06	2.71e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—melanoma	9.96e-06	2.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—melanoma	9.83e-06	2.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CA—melanoma	9.81e-06	2.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MDM2—melanoma	9.8e-06	2.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—melanoma	9.8e-06	2.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1A—melanoma	9.76e-06	2.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTEN—melanoma	9.74e-06	2.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFKB1—melanoma	9.69e-06	2.63e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB2—melanoma	9.66e-06	2.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CB—melanoma	9.53e-06	2.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—melanoma	9.51e-06	2.58e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—melanoma	9.41e-06	2.55e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CD—melanoma	9.16e-06	2.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—melanoma	9.08e-06	2.46e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—melanoma	9.04e-06	2.45e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1B—melanoma	8.95e-06	2.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—melanoma	8.8e-06	2.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—melanoma	8.71e-06	2.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTEN—melanoma	8.69e-06	2.35e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NRAS—melanoma	8.69e-06	2.35e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—melanoma	8.69e-06	2.35e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—melanoma	8.68e-06	2.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CTNNB1—melanoma	8.45e-06	2.29e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK3—melanoma	8.32e-06	2.25e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1A—melanoma	8.26e-06	2.24e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTEN—melanoma	8.24e-06	2.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—melanoma	8.09e-06	2.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—melanoma	8.01e-06	2.17e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CB—melanoma	7.98e-06	2.16e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK1—melanoma	7.92e-06	2.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—melanoma	7.92e-06	2.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KRAS—melanoma	7.48e-06	2.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—melanoma	7.37e-06	2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NRAS—melanoma	7.35e-06	1.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAPK3—melanoma	7.04e-06	1.91e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTEN—melanoma	6.9e-06	1.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CA—melanoma	6.87e-06	1.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—melanoma	6.85e-06	1.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAPK1—melanoma	6.7e-06	1.81e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—melanoma	6.7e-06	1.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—melanoma	6.65e-06	1.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—melanoma	6.36e-06	1.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KRAS—melanoma	6.33e-06	1.71e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CA—melanoma	6.13e-06	1.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—melanoma	6.08e-06	1.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CA—melanoma	5.81e-06	1.57e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—melanoma	5.61e-06	1.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—melanoma	5.38e-06	1.46e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—melanoma	5.15e-06	1.39e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—melanoma	5.01e-06	1.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CA—melanoma	4.87e-06	1.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—melanoma	4.75e-06	1.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—melanoma	3.98e-06	1.08e-05	CbGpPWpGaD
